cephalexin has been researched along with dicloxacillin in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (48.28) | 18.7374 |
1990's | 4 (13.79) | 18.2507 |
2000's | 5 (17.24) | 29.6817 |
2010's | 5 (17.24) | 24.3611 |
2020's | 1 (3.45) | 2.80 |
Authors | Studies |
---|---|
Brandsch, M; Luckner, P | 1 |
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Prober, CG; Yeager, AS | 1 |
Fujimura, N; Yokoyama, R | 1 |
Blumenfeld, EL; Salvati, EA; Wilson, PD | 1 |
Baxter, R; Chapman, J; Drew, WL | 1 |
Blaser, J; Dudley, MN; Gilbert, D; Zinner, SH | 1 |
Baker, D; Dice, J; Harrison, CJ; Marks, MI; Sharma, BB; Welch, DF | 1 |
Garrod, LP | 1 |
Penzotti, SC; Poole, JW | 1 |
Shimizu, T | 1 |
Fedder, J; Götze, W; Koperska, K; Matz, K | 1 |
Gibaldi, M; Perrier, D | 1 |
Arata, J; Ikeda, M; Kashiwa, N | 1 |
Bartlett, RC; Marcon, MJ | 1 |
Dillon, HC | 1 |
Carney, DN; Fossieck, BE; Parker, RH | 1 |
Caramatti, C; Mangoni, L; Rizzoli, V | 1 |
Fernández Eire, P; Olivares Arnal, P; Patrón Romero, M | 1 |
Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
Lanier, J; Qui, MK; Shim, J | 1 |
Dilworth, T; Hernandez, BN; Kesner, J; Mercier, RC; Ryan, K; Thelen, H | 1 |
3 review(s) available for cephalexin and dicloxacillin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Choice among penicillins and cephalosporins.
Topics: Ampicillin; Carbenicillin; Cephalexin; Cephaloglycin; Cephaloridine; Cephalosporins; Cephalothin; Cloxacillin; Dicloxacillin; Halogens; Humans; Methicillin; Oxacillin; Penicillin G; Penicillin V; Penicillinase; Penicillins; Phenyl Ethers | 1974 |
Clinical inquiry: what is the best treatment for impetigo ?
Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Clindamycin; Cloxacillin; Dicloxacillin; Diterpenes; Erythromycin; Fusidic Acid; Gentamicins; Humans; Impetigo; Meta-Analysis as Topic; Mupirocin; Randomized Controlled Trials as Topic | 2014 |
3 trial(s) available for cephalexin and dicloxacillin
Article | Year |
---|---|
A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis.
Topics: Administration, Oral; Bacterial Infections; Biological Availability; Candida; Cephalexin; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Dicloxacillin; Drug Evaluation; Feces; Female; Haemophilus; Humans; Infant; Kinetics; Male; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
Treatment of staphylococcal skin infections: a comparison of cephalexin and dicloxacillin.
Topics: Abscess; Adolescent; Cellulitis; Cephalexin; Child; Child, Preschool; Dicloxacillin; Female; Humans; Impetigo; Infant; Male; Pyoderma; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections | 1983 |
Staphylococcal bacteremia in cancer patients: intravenous and oral antimicrobial therapy.
Topics: Administration, Oral; Cefazolin; Cephalexin; Cephalosporins; Cephalothin; Clinical Trials as Topic; Dicloxacillin; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Nafcillin; Neoplasms; Sepsis; Staphylococcal Infections | 1982 |
23 other study(ies) available for cephalexin and dicloxacillin
Article | Year |
---|---|
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
Use of the serum bactericidal titer to assess the adequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Cephalexin; Child; Child, Preschool; Dicloxacillin; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Infant; Injections, Intravenous; Methicillin; Nafcillin; Osteomyelitis; Penicillin V; Probenecid; Protein Binding | 1979 |
[Study of synergetic effect of ampicillin and dicloxacillin against urinary tract infection isolates (author's transl)].
Topics: Agar; Ampicillin; Bacteria; Cephalexin; Dicloxacillin; Drug Combinations; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Urinary Tract Infections | 1978 |
The problem of infection in total prosthetic arthroplasty of the hip.
Topics: Arthroplasty; Cephalexin; Cephalothin; Debridement; Dicloxacillin; Hip; Humans; Joint Prosthesis; Oxacillin; Postoperative Complications; Surgical Wound Infection | 1975 |
Comparison of bactericidal activity of five antibiotics against Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clindamycin; Dicloxacillin; Female; Humans; Male; Middle Aged; Serum Bactericidal Test; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Significance of "extravascular" protein binding for antimicrobial pharmacodynamics in an in vitro capillary model of infection.
Topics: Anti-Infective Agents; Bacterial Infections; Cephalexin; Dicloxacillin; Models, Biological; Protein Binding | 1990 |
Transport mechanisms of beta-lactam antibiotics across everted rat gut.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport, Active; Cephalexin; Cephaloglycin; Cephaloridine; Cephalosporins; Dicloxacillin; Glucose; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Nafcillin; Penicillin G; Penicillin V; Penicillins; Rats; Surface Tension; Time Factors | 1974 |
Studies on protein binding of cefazolin and other antibiotics.
Topics: Agar; Ampicillin; Animals; Anti-Bacterial Agents; Blood Proteins; Buffers; Cattle; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cloxacillin; Dicloxacillin; Diffusion; Dogs; Horses; Humans; In Vitro Techniques; Protein Binding; Rabbits; Rats; Serum Albumin; Species Specificity; Sulfides; Tetrazoles; Thiadiazoles; Ultrafiltration | 1974 |
[Effects of nebacetin and nebacetin dexamethasone on the growth of microorganisms in the root canal of the tooth (author's transl)].
Topics: Ampicillin; Bacitracin; Bacterial Infections; Carbenicillin; Cephalexin; Cephaloridine; Chloramphenicol; Colistin; Dexamethasone; Dicloxacillin; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Neomycin; Penicillin G; Penicillin Resistance; Root Canal Therapy; Streptococcal Infections; Streptococcus; Tetracycline; Tooth Diseases | 1974 |
Animal models for investigating intestinal drug absorption: various antibiotics.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Biological Assay; Cephalexin; Cephaloridine; Dicloxacillin; Doxycycline; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Models, Biological; Penicillin G; Rats; Spectrophotometry; Tetracycline; Time Factors | 1973 |
Antibiotic effects on bacterial counts in skin lesions of experimental staphylococcal skin infections in the hamster.
Topics: Animals; Anti-Bacterial Agents; Cephalexin; Cephaloridine; Cricetinae; Dicloxacillin; Gentamicins; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus | 1984 |
Laboratory evaluation of the serum dilution test in serious staphylococcal infection.
Topics: Anti-Bacterial Agents; Biological Availability; Cefazolin; Cephalexin; Culture Media; Dicloxacillin; Evaluation Studies as Topic; Humans; Oxacillin; Penicillin Resistance; Protein Binding; Serologic Tests; Staphylococcal Infections; Staphylococcus aureus | 1983 |
[Clinical evaluation of use of combinations of beta-lactamines in anti-infective therapy].
Topics: Aged; Bacterial Infections; Bronchitis; Cefadroxil; Cephalexin; Dicloxacillin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged | 1980 |
[Childhood hemangiopericytoma. Apropos of a case].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cephalexin; Child, Preschool; Clavicle; Dicloxacillin; Female; Hemangiopericytoma; Humans | 1993 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cephalexin; Dicloxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monobactams; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2023 |